Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

NCT06056804 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

DRUG: capecitabine
DRUG: tislelizumab
DRUG: thymalfasin
RADIATION: long-term radiotherapy

Sponsor

Beijing Friendship Hospital

Collaborators

[object Object]